Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novavax Inc (NQ: NVAX ) 13.79 +0.01 (+0.04%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Novavax Inc < Previous 1 2 3 4 Next > GameStop Raises $2.14 Billion, Meme Stocks Buzz Fuels Gains Watch: GME, PRSO, DYAI, VTAK, AMC June 13, 2024 Via AB Newswire Top 4 Large-Cap Stocks With Major Short Interest June 13, 2024 As meme stock mania continues, stocks with high short interest like Novavax, Upstart, C3.ai, and Comstock Resources may attract renewed interest. Via MarketBeat Exposures COVID-19 Spotlight June 2024: NASDAQ Stocks Under $2 Achieving Major Milestones TELL, DYAI, PRSO, SPEC, GME June 11, 2024 Via AB Newswire Topics Energy Exposures Fossil Fuels Meme Stocks Surge Led by ‘Roaring Kitty’ and Social Media Buzz on Reddit (NYSE: RDDT), GME, DYAI, AMC, PRSO, NVAX June 06, 2024 Via AB Newswire Novavax Inc. (NASDAQ: NVAX) Near the Top of Equities by Percentage Gain on 7/10 July 10, 2023 Via Investor Brand Network Exposures COVID-19 Novavax Inc. (NASDAQ: NVAX) Leading the Way in Tuesday Trading Based on Percentage Gain May 09, 2023 Via Investor Brand Network Exposures COVID-19 Novavax Stock’s Recent Surge and Future Potential June 06, 2024 Novavax's future hinges on its ability to translate recent stock market momentum into sustained financial performance. Via MarketBeat Topics Economy Exposures COVID-19 Product Safety Supply Chain Dyadic International Inc. (NASDAQ: DYAI) Hits New 52-Week High Amidst Golden Cross, Bullish Swing Patterns and Bird Flu Concerns June 06, 2024 Via AB Newswire Peraso Inc. (NASDAQ: PRSO) Announces Paradigm-Shifting mmWave Wi-Fi Advancements with Phased Array Antenna Technology June 06, 2024 Via AB Newswire Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns May 30, 2024 Via AB Newswire Exposures COVID-19 Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting May 20, 2024 From Shah Capital Via GlobeNewswire 5 Meme Stocks With a High Short Interest May 14, 2024 Keith Gill, aka RoaringKitty, resurfaces on Twitter, triggering a surge in GameStop and AMC Entertainment shares amid remarkable trading volume. Via MarketBeat Topics Economy Exposures Economy Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting May 06, 2024 From Shah Capital Via GlobeNewswire Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report May 06, 2024 After a painful two-year selloff, Pfizer shareholders may have finally gained a foothold after the company delivered a solid Q1 2024 earnings report Via MarketBeat Exposures COVID-19 Shah Capital nominates two highly qualified independent director candidates for Novavax April 15, 2024 From Shah Capital Via GlobeNewswire The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover April 09, 2024 Analysts rate the stocks, but who rates the analysts? This is a look at five of the highest-rated analysts tracked by Marketbeat.com based on 12-month ROI. Via MarketBeat Topics Cannabis Exposures Cannabis Exploring Stocks with High Short Interest: INBS, BLNK, BYND, NVAX, PLUG February 27, 2024 Via AB Newswire Topics Electric Vehicles Exposures COVID-19 Electric Vehicles Novavax’s dispute resolution and upcoming earnings call February 23, 2024 Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer. Via MarketBeat Topics Earnings Exposures COVID-19 Financial 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals September 01, 2023 The second quarter of the 2023 earnings season has drawn to a close. There were many surprises in every sector. However, there were some standout surprises with Via MarketBeat Exposures COVID-19 Is Novavax Finally Turning Things Around? May 15, 2023 Vaccine developer Novavax Inc. (NASDAQ: NVAX) stock shot up 28% following its Q1 2023 earnings report. The company specializes in vaccines for infectious disea Via MarketBeat Exposures COVID-19 A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats March 20, 2023 By Ernest Dela Aglanu, Benzinga Via TheNewswire.com Topics Death Economy Exposures COVID-19 Death Economy Coronavirus Vaccine Market To Surpass $95 Billion By 2028 February 28, 2023 EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END Via FinancialNewsMedia Exposures COVID-19 MarketBeat Week in Review – 1/30 - 2/3 February 04, 2023 The markets are trending lower to end the week. It’s hard to figure out the markets after the blockbuster job report, but the MarketBeat team gave it a shot Via MarketBeat Topics Artificial Intelligence Earnings Economy Exposures Artificial Intelligence Financial Interest Rates Novavax Shares Jumped in January While Others Slipped February 01, 2023 Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line. Via MarketBeat Exposures COVID-19 Product Safety River Private Wealth announces new round of investment in Novavax, Inc January 19, 2023 Via AB Newswire 2 Biotechs Making Waves With A Single Product in their Pipeline January 11, 2023 Catalyst Pharmaceuticals and Harmony Bioscience each have a single product in their respective pipelines, and both show incredible promise. Via MarketBeat While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants November 16, 2022 EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END Via FinancialNewsMedia Exposures COVID-19 Is Pfizer Stock Still Worth Buying After the Pandemic? October 12, 2022 Pharmaceutical giant Pfizer (NYSE: PFE) is literally synonymous with COVID-19 vaccines, and as a result, Pfizer stock continues to beat expectations. Via MarketBeat Exposures COVID-19 MarketBeat: Week in Review 9/19 – 9/23 September 24, 2022 The sell-off in the market confirms that the global economy is slowing. What should you do? Here are some insights our analysts delivered for you this week Via MarketBeat Topics Economy Exposures Economy Interest Rates Novavax Remains a Risk-On Stock in a Risk-Off Market September 22, 2022 NVAX is a risk-on stock at a time investors are turning to risk-off assets. This article looks to see if Novavax still presents an opportunity for investors Via MarketBeat Topics Earnings Exposures Financial < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.